Scientists engineered T cells to protect instead of kill, potentially enabling targeted treatments for autoimmune disease and ...

The manuscript addresses the 3D chromatin architecture in monocytes from patients with alcohol-associated hepatitis and its relationship to enhanced transcription of innate immune genes. While the ...

INmune Bio Inc. (NASDAQ: INMB) (the "Company"), a clinical-stage immunology and inflammation company, continues to advance its Natural Killer (NK) cell therapy, INKmune™, in a Phase I/II trial (the ...

University of Queensland research using natural killer cells may lead to the first new treatment for a devastating childhood ...